SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Merck & Co., Inc. Release: Patients with Type 2 Diabetes Fasting for Ramadan in India and Malaysia Were About Half as Likely to Experience Low Blood Sugar When Switched from a Sulfonylurea to MSD’s JANUVIA® (sitagliptin)
Your Message